risks of retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation GLP-1 drug users are Vitamin B2 Subscription:6-months

risks of retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation GLP-1 drug users are Vitamin B2 Subscription:6-months

GLP-1 drug users are known to have suppressed appetites and a preference for protein-rich foods. (Credit: Getty Images) #mcdonalds #glp1 #ozempic #fastfood

doi: 10.3389/fcdhc.2025.1638681 Received 31 May 2025 Accepted 04 July 2025 Published 17 September 2025 Volume 6 - 2025 Edited by Dimitrios Patoulias, Aristotle University of Thessaloniki, Greece Reviewed by Louisa K

Vitamin B2

Subscription:6-months

However, we did not observe consistent associations between changes in BP and UACR in either trial, suggesting that the reduced albuminuria in the retatrutide treatment groups was unlikely explained by concomitant reductions in BP